Neuroimaging in Leukemia

Hematol Oncol Clin North Am. 2016 Aug;30(4):823-42. doi: 10.1016/j.hoc.2016.03.006.

Abstract

Leukemias are a heterogeneous group of hematologic malignancies that results from uncontrolled neoplastic proliferation of undifferentiated or partially differentiated hematopoietic cells. Patients with acute leukemia can have a variety of craniocerebral complications, which can result from direct leukemic involvement, secondary to cerebrovascular or infectious complications of leukemia, or can be treatment related. Imaging plays a central role in evaluating the central nervous system during treatment in patients with leukemia. CT scan is usually considered an effective initial imaging modality to evaluate for cerebrovascular complications. MRI is considered the imaging modality of choice due to its versatility.

Keywords: CT; Central nervous system; Leukemia; Leukostasis; MRI; Neuroimaging.

Publication types

  • Review

MeSH terms

  • Central Nervous System Infections / diagnostic imaging*
  • Central Nervous System Infections / etiology
  • Central Nervous System Infections / therapy
  • Cerebrovascular Disorders / diagnostic imaging*
  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / therapy
  • Humans
  • Leukemia / diagnostic imaging*
  • Leukemia / therapy
  • Magnetic Resonance Imaging / methods*
  • Neuroimaging / methods*